Legal & General Group’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2
Closed -$1K 3470
2022
Q2
$1K Hold
2
﹤0.01% 3501
2022
Q1
$6K Hold
2
﹤0.01% 3486
2021
Q4
$6K Sell
2
-32
-94% -$148K ﹤0.01% 3534
2021
Q3
$220K Buy
34
+28
+467% +$242K ﹤0.01% 2654
2021
Q2
$77K Hold
6
﹤0.01% 2813
2021
Q1
$97K Hold
6
﹤0.01% 2629
2020
Q4
$100K Hold
6
﹤0.01% 2589
2020
Q3
$111K Sell
6
-1
-14% -$23K ﹤0.01% 2458
2020
Q2
$172K Buy
7
+6
+600% +$170K ﹤0.01% 2388
2020
Q1
$30K Sell
1
-1
-50% -$16K ﹤0.01% 2765
2019
Q4
$17K Hold
2
﹤0.01% 3221
2019
Q3
$16K Hold
2
﹤0.01% 3194
2019
Q2
$27K Buy
2
+1
+100% +$16.6K ﹤0.01% 3075
2019
Q1
$23K Hold
1
﹤0.01% 3045
2018
Q4
$10K Hold
1
﹤0.01% 3274
2018
Q3
$19K Hold
1
﹤0.01% 3219
2018
Q2
$27K Hold
1
﹤0.01% 3069
2018
Q1
$40K Hold
1
﹤0.01% 2853
2017
Q4
$35K Hold
1
﹤0.01% 2985
2017
Q3
$43K Buy
+1
New +$54.9K ﹤0.01% 2957

Other funds holding KALA

Legal & General Group's KALA Position: Q3 2022 in Review

Legal & General Group sold out of KALA BIO (KALA) in Q3 2022, closing a stake of 2 shares — an estimated $1K sold.

Legal & General Group first reported a position in KALA in Q3 2017 and held it in 20 quarters. The position peaked at $220K in Q3 2021. 53 funds tracked by Wall St. Rank hold KALA as of Q3 2022.

  • Legal & General Group reported no remaining KALA BIO position as of Q3 2022 after selling out during the quarter.
  • Legal & General Group sold 2 KALA BIO shares in Q3 2022, an estimated $1K.
  • Legal & General Group first reported a position in KALA BIO in Q3 2017 and held it in 20 quarters.
  • Legal & General Group's KALA BIO position peaked at $220K in Q3 2021.
  • 53 funds tracked by Wall St. Rank held KALA BIO as of Q3 2022.

Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.